Ascendis Pharma A/S (ASND) vs peers

$253.00

Latest weekly close · Market cap $16.6B

ASND's P/S is not meaningful or is unavailable. Choose another measure to compare peers.

Peer group: Biotechnology. Updated Oct 30, 2026.

ASND and Biotechnology, ranked by P/S
Stock	P/S	Own 5-year percentile
ASNDAscendis Pharma A/S	n/m	n/m, not ranked
MRNAModerna	39.8×	99
NTRANatera Inc	23.1×	100
VRTXVertex Pharmaceuticals	11.0×	76
ABBVAbbVie	8.0×	100
GILDGilead Sciences	6.7×	100
AMGNAmgen	6.6×	100
REGNRegeneron Pharmaceuticals	5.6×	43
RVMDRevolution Medicines Inc	n/m	n/m, not ranked
Peer median	8.0×

How to read this comparison

Up to eight covered companies in the same industry, largest market value first.

P/S divides market value by revenue over the last twelve months. The peer median leaves out ASND and stocks without a reading.

Each percentile compares a stock with its own weekly readings over the last five years, so 20 means its P/S is above 20% of its own past readings. It needs at least 26 weeks of history. It is not a rank against the other stocks in this table.

Different growth rates, margins and financial risks can explain different multiples. Stocks without positive revenue have no reading.

ASND versus the peer median

n/m

ASND: n/m
Peer median: 8.0×
Own 5-year median: n/m

ASND P/S history Calculate ASND's implied price